The Petri Dish: Beam’s acquisition; cancer startup gets $95M

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here’s The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings.…

Read More

Boston Private investor campaigns to vote down $900M SVB deal

HoldCo Asset Management reiterated that the $900 million offer undervalues Boston Private’s deposit franchise and wealth management business. The firm believes Boston Private CEO Anthony DeChellis has an “irreconcilable conflict of interest” because he will take on a senior executive role with Silicon Valley following the transaction, it said. Read More

Read More

Moderna ramps up manufacturing capacity to 1.4B doses for 2022

Cambridge biotech Moderna is increasing its manufacturing capacity of the Covid-19 vaccine over the next two years: to 700 million doses in 2021, up from 600 million, and to 1.4 billion doses in 2022. The company is also exploring whether its coronavirus vaccine can be administered at a lower dose. Read More

Read More